دورية أكاديمية
Severe hypophosphatemia secondary to chronic treatment with endovenous ferric carboxymaltose.
العنوان: | Severe hypophosphatemia secondary to chronic treatment with endovenous ferric carboxymaltose. |
---|---|
المؤلفون: | González Hidalgo V; Servicio de Medicina Interna del Hospital Virgen del Puerto, Plasencia, Cáceres, Spain. Electronic address: virginiagonhid@gmail.com., Morán López JM; Servicio de Endocrinología y Nutrición del Hospital Virgen del Puerto, Plasencia, Cáceres, Spain. |
المصدر: | Endocrinologia, diabetes y nutricion [Endocrinol Diabetes Nutr (Engl Ed)] 2022 Oct; Vol. 69 (8), pp. 646-647. Date of Electronic Publication: 2022 Nov 02. |
نوع المنشور: | Case Reports; Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Country of Publication: Spain NLM ID: 101717565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2530-0180 (Electronic) Linking ISSN: 25300180 NLM ISO Abbreviation: Endocrinol Diabetes Nutr (Engl Ed) Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Barcelona] : [Elsevier España], 2017- |
مواضيع طبية MeSH: | Maltose*/adverse effects , Hypophosphatemia*/chemically induced, Humans ; Ferric Compounds/adverse effects |
المشرفين على المادة: | 6897GXD6OE (ferric carboxymaltose) 69-79-4 (Maltose) 0 (Ferric Compounds) |
تواريخ الأحداث: | Date Created: 20221105 Date Completed: 20221201 Latest Revision: 20221206 |
رمز التحديث: | 20221213 |
DOI: | 10.1016/j.endien.2021.09.002 |
PMID: | 36335081 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2530-0180 |
---|---|
DOI: | 10.1016/j.endien.2021.09.002 |